Anna-Karin Pernestig
- Molecular Biology
- Genetics top 10%
- Endocrinology top 2%
- Epidemiology
- Cancer Research
- Co-authors
- Öjar MeleforsDimitris GeorgellisDiana TilevikKazushi SuzukiTony RomeoXin WangPaul BabitzkeLars Ljungström
- Topics
- Escherichia coli research studies (5 papers)Bacterial Genetics and Biotechnology (4 papers)Sepsis Diagnosis and Treatment (4 papers)
- Partner nations
- SwedenMexicoUnited States
In The Last Decade
Anna-Karin Pernestig
15 papers receiving 883 citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 529
- Genetics 312
- Endocrinology 222
- Epidemiology 160
- Cancer Research 106
Countries citing papers authored by Anna-Karin Pernestig
This map shows the geographic impact of Anna-Karin Pernestig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna-Karin Pernestig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna-Karin Pernestig more than expected).
Fields of papers citing papers by Anna-Karin Pernestig
This network shows the impact of papers produced by Anna-Karin Pernestig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna-Karin Pernestig. The network helps show where Anna-Karin Pernestig may publish in the future.
Co-authorship network of co-authors of Anna-Karin Pernestig
This figure shows the co-authorship network connecting the top 25 collaborators of Anna-Karin Pernestig. A scholar is included among the top collaborators of Anna-Karin Pernestig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna-Karin Pernestig. Anna-Karin Pernestig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 15 | |
| 4 | 11 | |
| 5 | 186 | |
| 6 | 137 | |
| 7 | Evaluation of the QuickFISH and the Sepsityper assays for early identification of etiological agents in bloodstream infection in a clinical routine setting | 1 |
| 8 | 22 | |
| 9 | 8 | |
| 10 | Multimarker approach for sepsis diagnostics | 2 |
| 11 | 2 | |
| 12 | 32 | |
| 13 | 4 | |
| 14 | 26 | |
| 15 | 87 | |
| 16 | 233 | |
| 17 | 133 |
About Anna-Karin Pernestig
Anna-Karin Pernestig is a scholar working on Endocrinology, Molecular Medicine and Clinical Biochemistry, having authored 17 papers that have together received 901 indexed citations. Recurring topics across this work include Escherichia coli research studies (5 papers), Bacterial Genetics and Biotechnology (4 papers) and Sepsis Diagnosis and Treatment (4 papers). The work is most often cited by research in Endocrinology (222 citations), Molecular Medicine (72 citations) and Genetics (312 citations). Anna-Karin Pernestig has collaborated with scholars based in Sweden, Mexico and United States. Frequent co-authors include Öjar Melefors, Dimitris Georgellis, Diana Tilevik, Kazushi Suzuki, Tony Romeo, Xin Wang, Paul Babitzke, Lars Ljungström, Rune Andersson and Gunnar Jacobsson. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Bacteriology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.